N-(4-(Diethylamino)phenethyl)-4-hydroxybenzamide
CAS: 2213490-89-0
Ref. 3D-NND49089
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
N-(4-(Diethylamino)phenethyl)-4-hydroxybenzamide (NDEA) is a drug that inhibits the enzyme 11β-hydroxysteroid dehydrogenase type 1, which converts cortisone to cortisol. It has been used in clinical trials for the treatment of acute and chronic inflammatory diseases, such as rheumatoid arthritis and ulcerative colitis. NDEA has been shown to inhibit the proliferation of neural progenitor cells in culture, thereby causing a decrease in neurogenesis. This effect may be due to its ability to inhibit glucocorticoid receptors on neural stem cells. This molecule also inhibits cell proliferation in cultured mouse hippocampal neurons.
Chemical properties
Technical inquiry about: 3D-NND49089 N-(4-(Diethylamino)phenethyl)-4-hydroxybenzamide
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
